- Home
- BLDR vs BGNE Comparison
BLDR vs BGNE Comparison
Compare BLDR & BGNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLDR
- BGNE
- Stock Information
- Founded
- BLDR 1998
- BGNE 2010
- Country
- BLDR United States
- BGNE Cayman Islands
- Employees
- BLDR N/A
- BGNE N/A
- Industry
- BLDR RETAIL: Building Materials
- BGNE Biotechnology: Pharmaceutical Preparations
- Sector
- BLDR Consumer Discretionary
- BGNE Health Care
- Exchange
- BLDR Nasdaq
- BGNE Nasdaq
- Market Cap
- BLDR 20.2B
- BGNE 19.2B
- IPO Year
- BLDR 2005
- BGNE 2016
- Fundamental
- Price
- BLDR $152.02
- BGNE $175.87
- Analyst Decision
- BLDR Strong Buy
- BGNE Buy
- Analyst Count
- BLDR 16
- BGNE 8
- Target Price
- BLDR $210.00
- BGNE $253.69
- AVG Volume (30 Days)
- BLDR 1.1M
- BGNE 476.1K
- Earning Date
- BLDR 11-05-2024
- BGNE 11-12-2024
- Dividend Yield
- BLDR N/A
- BGNE N/A
- EPS Growth
- BLDR N/A
- BGNE N/A
- EPS
- BLDR 10.23
- BGNE N/A
- Revenue
- BLDR $16,731,047,999.00
- BGNE $3,351,304,621.00
- Revenue This Year
- BLDR N/A
- BGNE $969.39
- Revenue Next Year
- BLDR $4.74
- BGNE $24.79
- P/E Ratio
- BLDR $14.86
- BGNE N/A
- Revenue Growth
- BLDR N/A
- BGNE 50.22
- 52 Week Low
- BLDR $130.75
- BGNE $126.97
- 52 Week High
- BLDR $214.70
- BGNE $248.16
- Technical
- Relative Strength Index (RSI)
- BLDR 24.13
- BGNE 34.52
- Support Level
- BLDR $170.64
- BGNE $174.50
- Resistance Level
- BLDR $179.93
- BGNE $180.00
- Average True Range (ATR)
- BLDR 4.94
- BGNE 6.73
- MACD
- BLDR -2.58
- BGNE -2.17
- Stochastic Oscillator
- BLDR 0.76
- BGNE 3.24
About BLDR Builders FirstSource Inc.
Builders FirstSource Inc is a manufacturer and supplier of building materials. The company offers structural and related building products such as factory-built roof and floor trusses, wall panels and stairs, vinyl windows, custom millwork and trim, and engineered wood. The products can be designed for each home individually and are installed by Builders FirstSource. The company's construction-related services include professional installation, turn-key framing, and shell construction. Builders FirstSource's customers range from large production builders to small custom homebuilders.
About BGNE BeiGene Ltd.
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeiGene runs global clinical trials with its own team. As of 2023, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 50% of BeiGene's revenue.